YOLFTbeta
Scinai Immunotherapeutics Ltd

Scinai Immunotherapeutics Ltd

SCNI · NASDAQ · Healthcare / Biotechnology

0.40USD-0.04 (-9.50%)

Price History

Full chart

Market Stats

Previous Close0.442
Open0.4458
Day Range0.387 – 0.4458
52-Week Range1.43 – 16.30
Volume94.99K
Market Cap1.05M
P/E (TTM)0.06
Forward P/E0.00
EPS28.07
Dividend Yield0.00%
Beta2.08
50-Day Avg2.32
200-Day Avg5.41

About

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis. The company also offers contract development and manufacturing organization services, such as analytical method development, process development, and cGMP manufacturing of clinical-stage materials to early-stage biotechnology companies. It has collaboration partnerships with Max Planck Society and University Medical Center Gottingen for the development of NanoAb candidates; and Recipharm Israel Ltd for the development of biologics and small-molecule programs. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is based in Jerusalem, Israel.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Amir Reichman M.B.A., M.Sc.
  • Employees45
  • HeadquartersJerusalem BioPark, Jerusalem, Israel, USA
  • Websitehttps://www.scinai.com

Leadership

  • Mr. Amir Reichman M.B.A., M.Sc.CEO & Director · b. 1976
  • Mr. Uri Ben-Or CPA, M.B.A.Chief Financial Officer · b. 1970
  • Mr. Elad Mark B.Sc., Eng., M.B.A.Chief Operating Officer · b. 1983
  • Gal RonHead of HR
  • Merav KamenskyHead of Quality Control & GMP Analytics
  • Dr. Naama Adi HenHead of Quality Asurance
  • Mr. Eran KuratzHead of Supply Chain & Business Process Administration

Financials

Income Statement

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--1.24M2.83M5.83M1.60M2.50M1.37M-----------00000658.00K1.31M
Growth (%)---+128.28%+105.93%-72.64%+56.45%-45.25%-----------------+99.24%
Cost of Revenue--309.00K741.00K1.67M640.00K1.41M969.00K73.42K66.96K76.22K167.98K-----123.55K72.32K461.69K708.92K747.65K559.80K512.67K1.24M3.96M
Gross Profit--932.00K2.09M4.17M956.00K1.09M398.00K-73.42K-66.96K-76.22K-168.00K---------708.92K-747.65K-559.80K-512.67K-580.00K-2.65M
Gross Margin--75.10%73.84%71.44%59.90%43.57%29.11%-----------------88.15%-202.29%
Operating Expense---1.95M3.22M---1.23M1.11M2.47M2.13M--------19.11M10.05M10.50M9.19M8.06M4.89M
Operating Income---141.00K946.00K----1.30M-1.17M-2.54M-2.30M-2.38M-2.20M-2.09M-2.90M-3.09M-6.80M-20.61M-22.69M-19.82M-10.79M-11.06M-9.71M-8.64M-7.54M
Operating Margin---4.98%16.22%--------------------1312.77%-575.29%
EBITDA---------1.14M-1.10M-2.41M-1.99M-2.24M-2.00M-1.92M-2.74M-2.93M-6.67M-20.54M-22.21M-19.11M-10.05M-5.23M-2.19M-6.99M-6.53M
EBITDA Margin-------------------------1062.16%-497.86%
Net Income----1.05M----1.21M-1.17M-2.49M-2.16M-2.43M-2.32M-1.99M-2.62M-2.38M-9.93M-23.46M-31.62M-1.30M-12.38M-5.80M-6.50M4.80M-8.31M
Net Income Margin----18.05%-------------------728.88%-633.64%
R&D--799.00K530.00K505.00K147.00K38.00K35.00K882.39K805.34K1.80M1.53M1.61M1.94M1.65M1.91M2.44M5.58M19.27M19.88M14.42M2.62M5.76M5.21M5.53M2.37M
R&D as % of Total Revenue--64.38%18.71%8.66%9.21%1.52%2.56%----------------840.73%180.70%
Interest Expense00000000-----1.43K1.69K7.810020.45K3.78M4.28M338.76K3.36M5.05M3.80M1.44M359.00K
Interest Expense % of Total Revenue--0.00%0.00%0.00%0.00%0.00%0.00%----------------218.66%27.38%

Balance Sheet

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.00K1.00K1.70M2.44M5.15M3.35M1.98M592.00K3.20M8.95M8.68M7.16M6.22M7.45M4.74M10.60M7.82M23.48M28.30M33.52M17.71M32.04M27.07M17.47M13.45M11.63M
Total Liabilities27.00K5.00K1.61M1.80M1.04M643.00K240.00K3.91M197.78K512.67K742.07K450.86K272.58K529.76K481.23K1.99M1.17M7.31M36.65M52.36M22.25M31.05M28.83M22.04M3.47M3.52M
Total Equity-24.00K-4.00K90.00K648.00K4.11M2.70M1.74M-3.31M3.00M8.44M7.94M6.71M5.95M6.92M4.26M8.61M6.65M16.17M-8.35M-18.84M-4.54M982.00K-1.76M-4.57M9.98M8.10M
Cash3.00K1.00K31.00K170.00K1.46M1.17M688.00K5.00K55.07K230.73K576.32K367.70K2.55M5.15M2.47M8.59M4.08M20.51M20.29M20.98M2.93M17.37M14.07M4.87M1.96M1.66M
Total Debt------------------25.23M38.02M20.90M29.23M21.54M20.56M2.09M2.27M
Net Debt---------55.07K-230.73K-576.32K-367.70K-2.55M-5.15M-2.47M-8.59M-4.08M-20.51M4.94M17.03M17.97M11.86M7.47M15.69M122.00K606.00K

Cash Flow

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow------10.00K--852.95K-2.29M-2.71M-1.82M-1.21M-1.94M-2.63M-2.51M-2.89M-15.29M-22.31M-21.09M-7.43M-7.26M-9.38M-6.33M-6.03M
Investing Cash Flow---------568.04K-1.38M-778.01K-109.01K583.69K-46.20K-11.04K-2.03M1.94M-6.27M-2.08M-1.73M-139.00K-836.00K-637.00K-12.00K-24.00K
Financing Cash Flow10.00K10.00K600.00K580.00K1.90M399.00K-310.00K6.39M1.27M1.33M1.28M2.67M-200.70K8.66M-17.77M22.55M24.68M3.99M21.43M6.78M1.09M3.44M5.77M
Capital Expenditure0015.00K15.00K25.00K10.00K04.00K31.32K301.94K764.01K80.39K56.52K7.70K8.73K5.19K1.30M6.35M2.15M1.78M139.00K836.00K637.00K12.00K24.00K
Free Cash Flow---------884.27K-2.59M-3.47M-1.90M-1.27M-1.95M-2.64M-2.51M-4.18M-21.64M-24.47M-22.88M-7.57M-8.10M-10.02M-6.35M-6.05M
FCF to OCF--------103.67%113.17%128.23%104.41%104.66%100.40%100.33%100.21%144.86%141.49%109.64%108.45%101.87%111.51%106.79%100.19%100.40%

Earnings

Report DateJun 3, 2015Aug 23, 2015Nov 9, 2015Jun 1, 2016Aug 22, 2016Nov 28, 2016May 30, 2017Aug 31, 2017Nov 28, 2017Feb 3, 2018May 29, 2018Aug 22, 2018Nov 13, 2018Apr 30, 2019Aug 28, 2019Nov 26, 2019Jun 12, 2020Aug 20, 2020Jan 28, 2021May 13, 2021Aug 26, 2021Nov 30, 2021Mar 28, 2022Jun 1, 2022Aug 25, 2022Nov 30, 2022May 15, 2023Aug 11, 2023Oct 31, 2023Dec 31, 2023May 15, 2024Jul 2, 2024Nov 22, 2024Feb 26, 2025May 7, 2025Sep 2, 2025Nov 28, 2025Jun 10, 2026Aug 24, 2026
EPS Estimate--12.00-11.00--0.01-0.01-0.01--9.500.00--0.01-1.00-1.00-2.00-2.00-1.00-0.01-1.00-0.01---0.16-10.00-1.00-1.00-7.30-9.10-9.40-62.00-6.20---0.000.00---
EPS Actual-346.48-1.291.02-135.86-0.210.01-0.02-78.0611.43-0.02-1.39-0.03-0.27-3.89-5.10-1.44-2.87-0.103.05-1.14-0.01-0.010.01-23.93-0.610.29-12.00-12.008.00-240.00-24.00-4.3112.39-26.354.31-2.60-24.850.94-0.74
Surprise-89.25%109.31%--2000.00%152.00%-98.00%-220.32%---175.00%73.00%-289.00%-155.00%28.00%-187.00%-900.00%405.00%-11300.00%--106.25%-139.30%39.00%129.00%-64.38%-31.87%185.11%-287.10%-287.10%--------
Timing-After-hoursPre-market----Pre-marketPre-market-Pre-market-After-hoursPre-marketPre-marketPre-marketPre-market-After-hours----Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hoursPre-market-------

Key Statistics & Ratios

Market Cap1.05M
Enterprise Value7.89M
Trailing P/E0.06
Forward P/E0.00
Price / Sales0.71
Price / Book0.22
EPS28.07
Book Value10.71
Revenue (TTM)1.49M
Gross Profit (TTM)-3.75M
EBITDA-6.64M
Profit Margin-174.78%
Operating Margin-466.52%
Return on Equity-26.53%
Return on Assets-36.15%
Shares Outstanding677.58K
Shares Float488.73K
Beta2.08
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 700.00
  • Strong Buy
    1

Ownership Breakdown

Institutions
4.29%
Insiders
14.16%
Retail / Other
81.55%

Top Institutional Holders

  • XTX Topco Ltd
    24.04K0.61%
  • Rhumbline Advisers
    1.88K0.05%
  • UBS Group AG
    9190.02%
  • Morgan Stanley - Brokerage Accounts
    580.00%
  • Northwestern Mutual Wealth Management Co
    00.00%
  • Virtu Financial LLC
    00.00%
  • Citadel Advisors Llc
    00.00%

Top Fund Holders

  • State Street® SPDR® Ptf Dev Wld exUS ETF
    20.00%

Stock Splits

  • Aug 21, 20261:10
  • May 21, 20241:10
  • Nov 25, 20221:10